Articles Published in 2012

BioCryst Pharmaceuticals to merge with Presidio Pharmaceuticals

Friday, October 19, 2012 11:34 AM

BioCryst Pharmaceuticals, a Durham, N.C.-based and developer of novel small molecule drugs that block key enzymes involved in infectious and inflammatory diseases, and Presidio Pharmaceuticals, a San Francisco-based clinical stage specialty pharmaceutical company, have signed a definitive merger agreement for Presidio to be acquired by BioCryst in an all-stock transaction.

More... »

Merck Serono, Auxogyn collaborate on Eeva Test

Friday, October 19, 2012 11:01 AM

Merck Serono, the biopharmaceutical division of Merck, and Auxogyn, a company focused on translating scientific discoveries in early embryo development into clinical tools, have entered into a strategic agreement focused on Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

More... »

SpringFire Laboratory Network adds ReproSource to affiliate laboratories

Friday, October 19, 2012 10:32 AM

SpringFire Laboratory Network, a network of independent, esoteric, high complexity laboratories, has added ReproSource Fertility Diagnostics, a Boston-based clinical laboratory and research organization that provides solutions for fertility testing and education, to its network of affiliate laboratories, which provides specialized testing services to clinical trial sponsors and CROs.

More... »

Danone Research deploys IDBS data and process management platform

Wednesday, October 17, 2012 03:57 PM

IDBS, a provider of innovative data and process management, analytics and modelling software, announced that Danone Research, Center for Specialized Nutrition—a life sciences innovation unit for the development of new product concepts for baby nutrition and medical nutrition—has implemented IDBS’ E-WorkBook.

More... »

MMG, Remedy Health to bolster clinical trial enrollment

Wednesday, October 17, 2012 03:46 PM

MMG, a global health communications company specializing in clinical trial patient recruitment and retention, has formed an exclusive partnership with Remedy Health Media, a health information and technology company, to deliver unique access to a larger pool of qualified potential clinical trial participants.

More... »

FDA approves Jetrea for symptomatic VMA in eyes

Wednesday, October 17, 2012 02:47 PM

The FDA has approved ThromboGenics’ Jetrea (ocriplasmin), the first drug approved to treat an eye condition called symptomatic vitreomacular adhesion (VMA).

More... »

Icon launches new medical imaging solution for early trials

Wednesday, October 17, 2012 12:27 PM

Icon,a global provider of outsourced development services, has launched a new medical imaging solution tailored to the unique requirements of early phase trials.

More... »

Clinical research sites honor Eli Lilly, Medpace with Eagle Awards

Monday, October 15, 2012 11:57 AM

The 2012 Eagle Awards, presented to the top sponsor and top CRO as voted by clinical research sites, honored Eli Lilly and Medpace on Saturday, Oct. 13, at the annual Site Solutions Summit.

More... »

Oramed, Medpace to collaborate on phase II trial

Monday, October 15, 2012 11:54 AM

Oramed, a subsidiary of Jerusalem-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has retained Medpace as CRO for Oramed's upcoming phase II clinical trial on its oral insulin capsule, ORMD-0801.

More... »

Pharmaron forms strategic partnership with AstraZeneca

Monday, October 15, 2012 11:47 AM

Pharmaron, an R&D service provider for the pharmaceutical and biotech industries, is partnering with AstraZeneca to support its global innovative medicines units.

More... »